Revenue Breakdown
Composition ()
No data
Revenue Streams
OraSure Technologies Inc (OSUR) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Net product and services revenues - HIV, accounting for 53.5% of total sales, equivalent to $14.50M. Other significant revenue streams include Net product and services revenues - Microbiome and Other revenues - Other non Product revenues. Understanding this composition is critical for investors evaluating how OSUR navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, OraSure Technologies Inc maintains a gross margin of 43.46%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -58.02%, while the net margin is -50.63%. These profitability ratios, combined with a Return on Equity (ROE) of -15.30%, provide a clear picture of how effectively OSUR converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, OSUR competes directly with industry leaders such as CVRX and SMTI. With a market capitalization of $198.34M, it holds a leading position in the sector. When comparing efficiency, OSUR's gross margin of 43.46% stands against CVRX's 86.81% and SMTI's 90.56%. Such benchmarking helps identify whether OraSure Technologies Inc is trading at a premium or discount relative to its financial performance.
